Roser Escrig

Statistics

Publications

Citations

248

H-Index

Active since

2014

Affiliations

Hospital Universitari Germans Trias i Pujol(Current)

Universitat Autònoma de Barcelona

Universitat de Vic - Universitat Central de Catalunya

Fundació Lluita contra les Infeccions

IrsiCaixa

Roser Escrig is an author at Hospital Universitari Germans Trias i Pujol specializing in infectious diseases, antiretroviral therapy, and antiviral therapy.

Publications per year

2014–2022

Publications

Therapeutic Vaccination Refocuses T-cell Responses Towards Conserved Regions of HIV-1 in Early Treated Individuals (BCN 01 study)

Beatriz Mothe, Christian Manzardo, Álvaro Sánchez-Bernabéu et al. · EClinicalMedicine · 2019 · 64 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

Gut microbiome signatures linked to HIV-1 reservoir size and viremia control

Alessandra Borgognone, Marc Noguera-Julián, Bruna Oriol-Tordera et al. · Microbiome · 2022 · 58 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Improvement in bone mineral density after switching from tenofovir to abacavir in HIV-1-infected patients with low bone mineral density: two-centre randomized pilot study (OsteoTDF study)

Eugènia Negredo, Peré Domingo, Núria Pérez‐Álvarez et al. · Journal of Antimicrobial Chemotherapy · 2014 · 48 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Switching from tenofovir to abacavir in HIV-1-infected patients with low bone mineral density: changes in bone turnover markers and circulating sclerostin levels

Eugènia Negredo, Adolfo Díez‐Pérez, Anna Bonjoch et al. · Journal of Antimicrobial Chemotherapy · 2015 · 28 citations · Full text

Medicine, Infectious Diseases, Bone Metabolism +16

Single oral dose of maraviroc does not prevent ex-vivo HIV infection of rectal mucosa in HIV-1 negative human volunteers

J Coll, José Moltó, Jaume Boix et al. · AIDS · 2015 · 18 citations

Public Health, Infectious Diseases, Pharmacotherapy +17

1–5 of 7